Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Nektar Therapeutics (NKTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,498,249
  • Shares Outstanding, K 172,470
  • Annual Sales, $ 307,710 K
  • Annual Income, $ -96,690 K
  • 36-Month Beta 2.26
  • Price/Sales 331.34
  • Price/Cash Flow N/A
  • Price/Book 5.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.58
  • Number of Estimates 6
  • High Estimate -0.30
  • Low Estimate -0.73
  • Prior Year 0.37
  • Growth Rate Est. (year over year) -256.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.59 +9.98%
on 09/19/18
69.76 -12.36%
on 09/05/18
-2.75 (-4.30%)
since 08/24/18
3-Month
44.51 +37.36%
on 06/28/18
69.76 -12.36%
on 09/05/18
+9.87 (+19.25%)
since 06/25/18
52-Week
22.02 +177.66%
on 09/26/17
111.36 -45.10%
on 03/12/18
+38.22 (+166.75%)
since 09/25/17

Most Recent Stories

More News
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (OMER , ECYT, NKTR , HZNP , SUPN )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

ECYT : 18.38 (+0.77%)
OMER : 25.80 (-2.49%)
NKTR : 61.14 (+0.44%)
Nektar Therapeut Falls 3.41% on Heavy Volume: Watch For Potential Rebound

Nektar Therapeut (NASDAQ:NKTR) traded in a range yesterday that spanned from a low of $55.59 to a high of $58.75. Yesterday, the shares fell 3.4%, which took the trading range below the 3-day low of...

NKTR : 61.14 (+0.44%)
Best Relative Performance in the Pharmaceuticals Industry Detected in Shares of Endocyte Inc (ECYT, NKTR , OMER , TXMD , DERM )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

ECYT : 18.38 (+0.77%)
OMER : 25.80 (-2.49%)
NKTR : 61.14 (+0.44%)
Lilly (LLY) Hits 52-Week High, Can the Run Continue?

Lilly (LLY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

FIXX : 22.71 (-0.61%)
LLY : 105.70 (+0.10%)
VRTX : 182.65 (+0.26%)
NKTR : 61.14 (+0.44%)
Why Is Nektar (NKTR) Up 11.2% Since Last Earnings Report?

Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NKTR : 61.14 (+0.44%)
Nektar Therapeut Up 22.2% Since SmarTrend Uptrend Call (NKTR)

SmarTrend identified an Uptrend for Nektar Therapeut (NASDAQ:NKTR) on August 6th, 2018 at $55.08. In approximately 1 month, Nektar Therapeut has returned 22.21% as of today's recent price of $67.31.

NKTR : 61.14 (+0.44%)
Endo (ENDP) Hits 52-Week High, Can the Run Continue?

Endo (ENDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

CELG : 87.57 (+0.01%)
ENDP : 16.25 (-0.25%)
LLY : 105.70 (+0.10%)
NKTR : 61.14 (+0.44%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (LCI , OMER , NKTR , ECYT, ZGNX )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

LCI : 4.85 (-3.00%)
ECYT : 18.38 (+0.77%)
OMER : 25.80 (-2.49%)
NKTR : 61.14 (+0.44%)
Nektar Therapeut Set to Possibly Pullback After Yesterday's Rally of 1.68%

Nektar Therapeut (NASDAQ:NKTR) traded in a range yesterday that spanned from a low of $65.60 to a high of $68.44. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high...

NKTR : 61.14 (+0.44%)
5 Health Care ETFs Outperforming XLV on YTD Basis

Health care ETFs provide handsome returns year to date.

LGND : 270.74 (+0.89%)
XLV : 94.17 (-0.31%)
XHE : 88.07 (+0.74%)
TNDM : 47.84 (+7.43%)
IHF : 196.94 (-0.64%)
FBT : 157.48 (+0.52%)
IHI : 226.81 (+0.70%)
MDT : 99.00 (+0.14%)
PSCH : 140.06 (-0.26%)
UNH : 263.51 (-1.44%)
NKTR : 61.14 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade NKTR with:

Business Summary

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to meet unmet medical needs and improve the benefits of drugs for patients. Its product pipeline consists...

See More

Key Turning Points

2nd Resistance Point 63.40
1st Resistance Point 62.27
Last Price 61.14
1st Support Level 60.14
2nd Support Level 59.14

See More

52-Week High 111.36
Fibonacci 61.8% 77.23
Fibonacci 50% 66.69
Last Price 61.14
Fibonacci 38.2% 56.15
52-Week Low 22.02

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar